Prognostic  ||| S:0 E:11 ||| JJ
factors  ||| S:11 E:19 ||| NNS
for  ||| S:19 E:23 ||| IN
complete  ||| S:23 E:32 ||| JJ
debulking  ||| S:32 E:42 ||| NN
in  ||| S:42 E:45 ||| IN
first-  ||| S:45 E:52 ||| JJ
and  ||| S:52 E:56 ||| CC
second-line  ||| S:56 E:68 ||| JJ
ovarian  ||| S:68 E:76 ||| JJ
cancer  ||| S:76 E:83 ||| NN
Surgery  ||| S:83 E:91 ||| NNP
is  ||| S:91 E:94 ||| VBZ
a  ||| S:94 E:96 ||| DT
mainstay  ||| S:96 E:105 ||| NN
of  ||| S:105 E:108 ||| IN
therapy  ||| S:108 E:116 ||| NN
in  ||| S:116 E:119 ||| IN
ovarian  ||| S:119 E:127 ||| JJ
cancer ||| S:127 E:133 ||| NN
.  ||| S:133 E:135 ||| .
Are  ||| S:135 E:139 ||| VBP
there  ||| S:139 E:145 ||| RB
any  ||| S:145 E:149 ||| DT
actual  ||| S:149 E:156 ||| JJ
changes  ||| S:156 E:164 ||| NNS
in  ||| S:164 E:167 ||| IN
the  ||| S:167 E:171 ||| DT
definitions  ||| S:171 E:183 ||| NNS
and  ||| S:183 E:187 ||| CC
goals  ||| S:187 E:193 ||| NNS
of  ||| S:193 E:196 ||| IN
surgery ||| S:196 E:203 ||| NN
?  ||| S:203 E:205 ||| .
Selective  ||| S:205 E:215 ||| JJ
review  ||| S:215 E:222 ||| NN
of  ||| S:222 E:225 ||| IN
the  ||| S:225 E:229 ||| DT
actual  ||| S:229 E:236 ||| JJ
literature  ||| S:236 E:247 ||| NN
and  ||| S:247 E:251 ||| CC
results  ||| S:251 E:259 ||| NNS
in  ||| S:259 E:262 ||| IN
surgery  ||| S:262 E:270 ||| NN
for  ||| S:270 E:274 ||| IN
primary  ||| S:274 E:282 ||| JJ
and  ||| S:282 E:286 ||| CC
recurrent  ||| S:286 E:296 ||| JJ
ovarian  ||| S:296 E:304 ||| JJ
cancer ||| S:304 E:310 ||| NN
.  ||| S:310 E:312 ||| .
Actual  ||| S:312 E:319 ||| JJ
data  ||| S:319 E:324 ||| NNS
strongly  ||| S:324 E:333 ||| RB
suggest  ||| S:333 E:341 ||| VBP
changing  ||| S:341 E:350 ||| VBG
the  ||| S:350 E:354 ||| DT
surgical  ||| S:354 E:363 ||| JJ
aim  ||| S:363 E:367 ||| NN
from  ||| S:367 E:372 ||| IN
the  ||| S:372 E:376 ||| DT
so-called  ||| S:376 E:386 ||| JJ
optimal  ||| S:386 E:394 ||| JJ
debulking  ||| S:394 E:404 ||| NNS
( ||| S:404 E:405 ||| -LRB-
residual  ||| S:405 E:414 ||| JJ
disease  ||| S:414 E:422 ||| NN
< ||| S:422 E:423 ||| SYM
1  ||| S:423 E:425 ||| CD
cm ||| S:425 E:427 ||| CD
)  ||| S:427 E:429 ||| -RRB-
to  ||| S:429 E:432 ||| TO
complete  ||| S:432 E:441 ||| VB
resection ||| S:441 E:450 ||| NNS
.  ||| S:450 E:452 ||| .
The  ||| S:452 E:456 ||| DT
standard  ||| S:456 E:465 ||| NN
in  ||| S:465 E:468 ||| IN
patients  ||| S:468 E:477 ||| NNS
in  ||| S:477 E:480 ||| IN
whom  ||| S:480 E:485 ||| WP
complete  ||| S:485 E:494 ||| JJ
resection  ||| S:494 E:504 ||| NN
might  ||| S:504 E:510 ||| MD
be  ||| S:510 E:513 ||| VB
possible  ||| S:513 E:522 ||| JJ
remains  ||| S:522 E:530 ||| VBZ
to  ||| S:530 E:533 ||| TO
be  ||| S:533 E:536 ||| VB
primary  ||| S:536 E:544 ||| JJ
surgery  ||| S:544 E:552 ||| NN
followed  ||| S:552 E:561 ||| VBN
by  ||| S:561 E:564 ||| IN
chemotherapy ||| S:564 E:576 ||| NN
.  ||| S:576 E:578 ||| .
There  ||| S:578 E:584 ||| EX
might  ||| S:584 E:590 ||| MD
be  ||| S:590 E:593 ||| VB
a  ||| S:593 E:595 ||| DT
subgroup  ||| S:595 E:604 ||| NN
of  ||| S:604 E:607 ||| IN
patients  ||| S:607 E:616 ||| NNS
with  ||| S:616 E:621 ||| IN
a  ||| S:621 E:623 ||| DT
poor  ||| S:623 E:628 ||| JJ
prognosis  ||| S:628 E:638 ||| NNS
who  ||| S:638 E:642 ||| WP
will  ||| S:642 E:647 ||| MD
have  ||| S:647 E:652 ||| VB
only  ||| S:652 E:657 ||| RB
limited  ||| S:657 E:665 ||| JJ
benefit  ||| S:665 E:673 ||| NN
of  ||| S:673 E:676 ||| IN
primary  ||| S:676 E:684 ||| JJ
surgery ||| S:684 E:691 ||| NN
,  ||| S:691 E:693 ||| ,
and  ||| S:693 E:697 ||| CC
interval  ||| S:697 E:706 ||| JJ
debulking  ||| S:706 E:716 ||| NN
is  ||| S:716 E:719 ||| VBZ
also  ||| S:719 E:724 ||| RB
possible ||| S:724 E:732 ||| JJ
.  ||| S:732 E:734 ||| .
Predictive  ||| S:734 E:745 ||| JJ
models  ||| S:745 E:752 ||| NNS
for  ||| S:752 E:756 ||| IN
suboptimal  ||| S:756 E:767 ||| JJ
debulking  ||| S:767 E:777 ||| NN
at  ||| S:777 E:780 ||| IN
primary  ||| S:780 E:788 ||| JJ
diagnosis  ||| S:788 E:798 ||| NNS
are  ||| S:798 E:802 ||| VBP
discussed ||| S:802 E:811 ||| VBN
.  ||| S:811 E:813 ||| .
The  ||| S:813 E:817 ||| DT
surgical  ||| S:817 E:826 ||| JJ
aim  ||| S:826 E:830 ||| NN
in  ||| S:830 E:833 ||| IN
recurrent  ||| S:833 E:843 ||| JJ
ovarian  ||| S:843 E:851 ||| JJ
cancer  ||| S:851 E:858 ||| NN
is  ||| S:858 E:861 ||| VBZ
defined  ||| S:861 E:869 ||| VBN
as  ||| S:869 E:872 ||| IN
complete  ||| S:872 E:881 ||| JJ
resection ||| S:881 E:890 ||| NN
.  ||| S:890 E:892 ||| .
Actual  ||| S:892 E:899 ||| JJ
multicenter  ||| S:899 E:911 ||| JJ
studies  ||| S:911 E:919 ||| NNS
investigated  ||| S:919 E:932 ||| VBD
prospectively  ||| S:932 E:946 ||| RB
predictive  ||| S:946 E:957 ||| JJ
models  ||| S:957 E:964 ||| NNS
for  ||| S:964 E:968 ||| IN
complete  ||| S:968 E:977 ||| JJ
resection ||| S:977 E:986 ||| NN
.  ||| S:986 E:988 ||| .
Recommendations  ||| S:988 E:1004 ||| NNS
regarding  ||| S:1004 E:1014 ||| VBG
surgical  ||| S:1014 E:1023 ||| JJ
aim  ||| S:1023 E:1027 ||| NN
have  ||| S:1027 E:1032 ||| VBP
changed  ||| S:1032 E:1040 ||| VBN
within  ||| S:1040 E:1047 ||| IN
the  ||| S:1047 E:1051 ||| DT
recent  ||| S:1051 E:1058 ||| JJ
years ||| S:1058 E:1063 ||| NNS
.  ||| S:1063 E:1065 ||| .
There  ||| S:1065 E:1071 ||| EX
are  ||| S:1071 E:1075 ||| VBP
still  ||| S:1075 E:1081 ||| RB
no  ||| S:1081 E:1084 ||| DT
reliable  ||| S:1084 E:1093 ||| JJ
predictive  ||| S:1093 E:1104 ||| JJ
models  ||| S:1104 E:1111 ||| NNS
for  ||| S:1111 E:1115 ||| IN
primary  ||| S:1115 E:1123 ||| JJ
surgery  ||| S:1123 E:1131 ||| NN
of  ||| S:1131 E:1134 ||| IN
ovarian  ||| S:1134 E:1142 ||| JJ
cancer ||| S:1142 E:1148 ||| NN
.  ||| S:1148 E:1150 ||| .
The  ||| S:1150 E:1154 ||| DT
DESKTOP  ||| S:1154 E:1162 ||| NNP
II  ||| S:1162 E:1165 ||| NNP
trial  ||| S:1165 E:1171 ||| NN
has  ||| S:1171 E:1175 ||| VBZ
validated  ||| S:1175 E:1185 ||| VBG
a  ||| S:1185 E:1187 ||| DT
score  ||| S:1187 E:1193 ||| NN
of  ||| S:1193 E:1196 ||| IN
resectability  ||| S:1196 E:1210 ||| NN
in  ||| S:1210 E:1213 ||| IN
recurrent  ||| S:1213 E:1223 ||| JJ
ovarian  ||| S:1223 E:1231 ||| JJ
cancer ||| S:1231 E:1237 ||| NN
.  ||| S:1237 E:1239 ||| .
